According to NRx Pharmaceuticals's latest financial reports the company has โน0.14 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | โน1.65 B | -19.23% |
2021-12-31 | โน2.05 B | 1411.28% |
2020-12-31 | โน0.13 B |